Brief: Lucira Receives CE Mark For Both COVID-19 & Flu And COVID-19 Molecular Tests
09/05/2022 13:19
May 9 (Reuters) - Lucira Health Inc LHDX.O :
* LUCIRA RECEIVES CE MARK FOR BOTH COVID-19 & FLU AND
COVID-19
MOLECULAR TESTS
Source text for Eikon: ID:nGNX6cThXr
Further company coverage: LHDX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lucira Health
See all newsBrief: Lucira Health Inc Filed Its Amended Chapter 11 Plan Of Liquidation With Bankruptcy Court
Brief: Lucira Health Files Proposed Chapter 11 Plan Of Liquidation
Brief: Bankruptcy Court Approves Lucira Health Assets Sale To Pfizer
Brief: Lucira Health Inc Says On April 6, 2023 Co Held Auction Relating To Disposition Of All Or Substantially All Of Company's Assets
Brief: Lucira Health Announces U.S. Launch Of First & Only At-Home Combination Covid-19 & Flu Test Amidst Sale Process